3. How are biosimilars approved in Europe and who decides on the availability?

This patient toolkit has been developed by ecancer in collaboration with the European Cancer Patient Coalition to provide patients with a comprehensive resource on biosimilar medicines. Six modules provide key information and practical advice to support you in making informed decisions for your treatment.

This e-learning resource is supported through an unrestricted education grant from Pfizer.